| Trial ID: | L3375 |
| Source ID: | NCT04426422
|
| Associated Drug: |
Metformin Hydrochloride
|
| Title: |
Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Metformin Hydrochloride
|
| Outcome Measures: |
Primary: gut micribiota, the changes of gut micribiota, 3 months | Secondary: glycemic control, HbA1c, 3 months
|
| Sponsor/Collaborators: |
Sponsor: Shenzhen People's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
52
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-03-01
|
| Completion Date: |
2018-09-30
|
| Results First Posted: |
|
| Last Update Posted: |
2020-06-11
|
| Locations: |
Shenzhen People' S Hospital, Shenzhen, Guangdong, 518000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT04426422
|
